Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021

Dustin D Flannery; Alvaro Zevallos Barboza; Kelly C Wade; Madeline R Pfeifer; Jeffrey S Gerber; Jeffrey S Morris; Karen M Puopolo

doi:10.1001/jama.2023.0166

Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021

JAMA. 2023 Feb 28;329(8):682-684. doi: 10.1001/jama.2023.0166.

Authors

Dustin D Flannery¹, Alvaro Zevallos Barboza¹, Kelly C Wade¹, Madeline R Pfeifer¹, Jeffrey S Gerber², Jeffrey S Morris³, Karen M Puopolo¹

Affiliations

¹ Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
² Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
³ Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia.

No abstract available

Plain language summary

This observational study explores whether rubella serostatus, which is routinely assessed during pregnancy, can serve as a proxy for measles serostatus in parturient persons.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
Hospitals
Humans
Measles* / epidemiology
Measles* / prevention & control
Measles-Mumps-Rubella Vaccine
Mumps*
Philadelphia / epidemiology
Rubella*
Vaccination

Substances

Antibodies, Viral
Measles-Mumps-Rubella Vaccine